Huan K. Nguyen

Huan K. Nguyen

Auto-generated profile, based on publicly available information

Huan K. Nguyen

Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Redox Biology
Verified
Journal Article
Open access
SWSteffen B. Wiegand
Steffen B. Wiegand
LTLisa Traeger
Lisa Traeger
HNHuan K. Nguyen
Huan K. Nguyen
KRKaitlyn R. Rouillard
Kaitlyn R. Rouillard
AFAnna Fischbach
Anna Fischbach
WZWarren M. Zapol
Warren M. Zapol
Inhalation of nitric oxide (NO) exerts selective pulmonary vasodilation. Nitric oxide also has an antimicrobial effect on a broad spectrum of pathogenic viruses, bacteria and fungi. The aim of this study was to investigate the effect of inhaled NO on bacterial burden and disease outcome in a murine model of Klebsiella pneumonia. Mice were infected with Klebsiella pneumoniae and inhaled either air alone, air mixed with constant levels of NO (at 80, 160, or 200 parts per million (ppm)) or air intermittently mixed with high dose NO (300 ppm). Forty-eight hours after airway inoculation, the number of viable bacteria in lung, spleen and blood was determined. The extent of infiltration of the lungs by inflammatory cells and the level of myeloperoxidase activity in the lungs were measured. Atomic force microscopy was used to investigate a possible mechanism by which nitric oxide exerts a bactericidal effect. Compared to control animals infected with K. pneumoniae and breathed air alone, intermittent breathing of NO (300ppm) reduced viable bacterial counts in lung and spleen tissue. Inhaled NO reduced infection-induced lung inflammation and improved overall survival of mice. NO destroyed the cell wall of K. pneumoniae and killed multiple-drug resistant K. pneumoniae in-vitro. Intermittent administration of high dose NO may be an effective approach to the treatment of pneumonia caused by K. pneumoniae.

19 September 2024 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
HNHuan K. Nguyen
Huan K. Nguyen
MDMagdalena M. Duke
Magdalena M. Duke
QGQuincy Grayton
Quincy Grayton
CBChristopher A. Broberg
Christopher A. Broberg
MSMark H. Schoenfisch
Mark H. Schoenfisch